Xencor Inc. 8-K Summary
Business Context and Reporting Period
Xencor Inc. filed a Current Report on Form 8-K dated March 1, 2016, with the report signed on April 27, 2016. The filing addresses Item 5.02 regarding the approval of the 2016 Executive Bonus Plan by the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements.
Material Changes
The primary material change is the adoption of the 2016 Executive Bonus Plan, which establishes performance-based compensation for executive officers based on corporate and individual goals.
Guidance, Outlook, and Management Commentary
The filing details the structure of the 2016 Bonus Plan, where bonuses are calculated as a percentage of base salary. Corporate goals include a combination of development, research, and business and financial targets. The plan includes target and maximum bonus opportunities tied to goal achievement.
Executive Bonus Plan Details
| Name | Title | Target Bonus (% of Base) | Maximum Bonus (% of Base) | Corporate Goal Weight | Individual Goal Weight |
|---|---|---|---|---|---|
| Bassil I. Dahiyat, Ph.D. | President and CEO | 50% | 65% | 100% | 0% |
| John R. Desjarlais, Ph.D. | SVP and Chief Scientific Officer | 35% | 40% | 50% | 50% |
| Paul Foster, M.D. | SVP and Chief Medical Officer | 35% | 40% | 50% | 50% |
| John J. Kuch | Vice President, Finance | 35% | 40% | 50% | 50% |
Investor Verification Checklist
- Verify the specific corporate and individual performance metrics defined for the 2016 Bonus Plan.
- Confirm the total potential cash outlay for executive bonuses based on current base salaries.
- Review subsequent filings for actual bonus payouts relative to the target and maximum percentages.
- Assess the impact of the 100% corporate goal weighting for the CEO on alignment with company-wide performance.